Insights & Analysis
There’s one constant in healthcare: change. Count on us to break down the trends so you can stay up to date. Follow our take on each piece of this deep, intertwined, and often perplexing industry to find opportunities and practical approaches to move healthcare forward.
Featured Content
Premium Content
Premium Content
Rethink Evidence Strategy this HEOR Budget Planning Season
Budgeting season offers HEOR teams the opportunity to revisit research and evidence needs and update their commercialization strategy based on market dynamics.
Drug Pricing Transparency Expands Under Several Policies
Transparency disclosures could provide significant insight into pricing and rebating activities.
Mental Health Treatment Integration Can Offer Cost Savings
Adequately treating mental health disorders can cut overall costs, including those from comorbidities, despite access barriers and high comorbidity expenses.
Most Women with Cervical Cancer Were Not Screened Before Diagnosis
An Avalere analysis shows that those who had received cervical cancer screening within five years prior to diagnosis were diagnosed at relatively younger ages.
A Deep Dive Into Hospice Utilization Trends
Avalere analysis reveals an opportunity to support more Medicare beneficiaries with hospice care, as evolving diagnoses and ALOS prompt reevaluation of program metrics
White Paper: Infusion Care and White-Bagging Requirements
Avalere surveyed providers on the administrative and economic costs of white-bagging requirements on infusion centers.
Patterns in Patient Access to MS Drugs
Avalere analysis finds that less clinically efficacious MS drugs have better coverage, more advantageous tiering, and lower UM compared to more efficacious drugs.
BIO International Convention Insights: Patient Assistance and Digital Therapeutics
At the 2024 BIO International Convention, Avalere led discussions on post-IRA patient access and affordability and reimbursement pathways for digital therapeutics.
Contract Pharmacy Trends May Help Inform 340B Reform Debate
As federal and state policymakers debate the role of contract pharmacies (CPs) in 340B, Avalere analyzed how CP relationships inform the policy landscape.
Avalere White Paper: RNA-Based Therapy Outlook
A white paper explores the RNA-based therapy pipeline and how FDA classifications can influence product development, commercialization, and patient access.
Addressing Sex and Gender Disparities in Cognitive Health
Women are more likely to experience reduced cognitive health later in life. Recent federal efforts seek to address the paucity of research on this phenomenon.
Can Comprehensive 340B Reform Generate Federal Savings?
Stakeholders are debating potential reforms to the 340B program, with specific policies directly or indirectly impacting federal spending.
MA Plans Increase Use of Step Therapy for Part B Drugs
In 2023, 54% of Medicare Advantage enrollees were in plans that required step therapy for 10 commonly used rheumatoid arthritis drugs covered under Part B.
Medicaid Managed Care Rule: Three Things Plans Should Know
CMS’s new Medicaid and CHIP managed care rule will impact wait time standards, In Lieu of Service and Setting usage, and quality rating.
What’s Next for Value-Based Care in Cardiology?
The prevalence and cost of CVD make cardiology a strong candidate for value-based care. Various clinical and market trends present opportunities for continued uptake.
Technology Is Driving Innovation in Women’s Health
The FemTech industry is rapidly growing and evolving as health equity and women’s health research become a larger focus and target priority in the US.
A Paradigm Shift in LDT Regulation
The FDA’s final rule to regulate LDTs as medical devices brings on numerous uncertainties for stakeholders.
Breast Cancer Screening Recommendations May Drive Inequities
New USPSTF breast cancer screening recommendations may not address the disparities experienced by Black women.
Health Plans 2030: Evolving Operational Approaches
The first installment of our Health Plans series explains how plans can evolve their approaches to provider contracting and utilization management for the future.
Adult Seasonal Combination Respiratory Vaccines: Policy Considerations
In a new white paper, Avalere considers key questions related to strain selection, ACIP recommendation, and coverage and reimbursement of adult combination vaccines in development.